Samer Alaiti, MD
NPI 1770591802 · Dermatology Physician · Los Angeles, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Samer Alaiti, MD is a Dermatology Physician provider in Los Angeles, CA (NPI 1770591802).
Provider details
- NPI number
- 1770591802
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- A51530 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
601 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 100 | $62 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 96 | $98 |
| Biopsy of Related Skin Growth, First Growth11102 | 81 | $99 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 79 | $8 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 62 | $187 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 35 | 21 |
| Cefadroxil | 33 | 21 |
| Mupirocin | 33 | 21 |
| Ketoconazole | 20 | — |
| Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone | 17 | — |
| Clobetasol Propionate | 14 | — |
| Dupilumabbrand: Dupixent Syringe | 12 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-04
- Last updated
- 2018-06-18
Frequently asked questions
- What is Samer Alaiti's NPI number?
- Samer Alaiti's National Provider Identifier (NPI) is 1770591802, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Samer Alaiti's specialty?
- Samer Alaiti is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Samer Alaiti located?
- Samer Alaiti's practice location on file with NPPES is 6200 Wilshire Blvd, Los Angeles, CA 90048-5801.
- What is Samer Alaiti's phone number?
- The practice phone number listed in the NPPES registry for Samer Alaiti is (323) 938-2626.
- Does Samer Alaiti accept Medicare?
- Samer Alaiti is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Samer Alaiti's NPI active?
- Yes — Samer Alaiti's NPI (1770591802) is active in the NPPES registry as of the last update on 2018-06-18.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.